Back to Search Start Over

Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis

Authors :
Francesco Volzone
Monica Morselli
Clodoveo Ferri
Leonardo Potenza
Fabio Ciceri
Fabio Forghieri
Patrizia Barozzi
Giovanni Riva
Mario Luppi
Chiara Bonini
Claudio Bordignon
Giulio Rossi
Denise Whitby
Raffaella Bosco
Thomas F. Schulz
Chiara Quadrelli
Daniela Vallerini
Giuseppe Torelli
Barozzi, P
Potenza, L
Riva, G
Vallerini, D
Quadrelli, C
Bosco, R
Morselli, M
Forghieri, F
Volzone, F
Rossi, G
Ferri, C
Bonini, MARIA CHIARA
Ciceri, Fabio
Bordignon, Claudio
Whitby, D
Schulz, Tf
Torelli, G
Luppi, M.
Source :
Seminars in Arthritis and Rheumatism. 39:170-175
Publication Year :
2009
Publisher :
Elsevier BV, 2009.

Abstract

Objectives: To describe the first in-depth analysis of both the T-cell responses against human herpesvirus-8 (HHV-8) and the HHV-8 viral load in 1 patient who developed iatrogenic HHV-8-associated-Kaposi's sarcoma (KS) following immunosuppressive treatment for undifferentiated arthritis and to review the literature on iatrogenic KS (IKS). Methods: T-cell responses against HHV-8 lytic and latent antigens were analyzed by ex vivo enzyme-linked immunospot (Elispot) and HHV-8 viral load was assessed by quantitative polymerase chain reaction, in sequential peripheral blood samples from a 55-year-old woman who developed skin/mucosal and visceral KS, while receiving treatment with cyclosporine, methotrexate, and methylprednisolone for undifferentiated arthritis. Results: KS may result from HHV-8 infection in patients undergoing immunosuppressive treatment for rheumatic diseases and this is the first case of IKS occurring in undifferentiated arthritis. A role for immune surveillance in the pathogenesis of IKS is supported by the observation of disease regression following discontinuation of immunosuppressive therapy. In a 4-year follow-up, we showed that variations of the virus-specific immune responses but not of the viral load correlated well with the disease course, characterized by 2 remission and subsequent relapse phases, following changes of immunosuppressive therapy. Conclusions: We have provided evidence of a clear-cut correlation between changes in immunologic markers of HHV-8 infection and the disease course of this viral associated tumor, concomitant with variations of immunosuppressive treatment. Thus, ex vivo enzyme-linked immunospot for HHV-8-specific T-cell responses represents a new tool for the clinical management of rheumatic patients with IKS. (C) 2009 Elsevier Inc. All rights reserved. Semin Arthritis Rheum 39:170-175 RI Rossi, Giulio/C-5576-2011

Details

ISSN :
00490172
Volume :
39
Database :
OpenAIRE
Journal :
Seminars in Arthritis and Rheumatism
Accession number :
edsair.doi.dedup.....5daf6baced590726fd68fdff244a1294